Future of Cell Therapy in the Regenerative Medicine Market

Research Overview This Frost & Sullivan research service analyses the current trends, forecasts and the external factors influencing the global cell therapy market. It also studies top participants in the market, disruptive pipeline products, and the opportunities in combination therapy. In addition, it provides a detailed commercialization analysis of research and development (R&D), manufacturing, and funding considerations.
Published: 25 May 2016

Future of Cell Therapy in the Regenerative Medicine Market

Combination Therapies and Advanced Manufacturing Techniques are the New Criteria Shaping the $4 Billion Market

This Frost & Sullivan research service analyses the current trends, forecasts and the external factors influencing the global cell therapy market. It also studies top participants in the market, disruptive pipeline products, and the opportunities in combination therapy. In addition, it provides a detailed commercialization analysis of research and development (R&D), manufacturing, and funding considerations.

Key Questions this Study will Answer

  • Will the cell therapy market  disrupt your current business or create growth opportunities? What do you need to know?
  • What are some of the key products and companies changing the dynamics of this market?
  • Where are the hottest segments in this market? Where is the most interest in terms of funding and innovation?
  • What are some of the most disruptive products by disease indication in this space?
  • What are the gaps in the market that encourage penetration and provide opportunities to new entrants?
  • How are countries refocusing funds and regulations to support this new market? Which countries are at the forefront of this change?

Features of this Research

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..